Placebo effects in a RCT assessing 30 days of low dose Cannabidiol (CBD) treatment for psychological distress in stressed students at risk for depression (2025)

Cannabidiol (CBD) has been suggested to have a therapeutic role for certain mental health conditions despite a lack of empirical evidence (Khan et al. 2020; Bonaccorso et al. 2019; Kirkland et al. 2022). The aim of the RCT (DRKS00030971) was to assess the effect of a daily sublingual application of